MicroVision Earnings Call: Strategy Advances, Results Lag

Microvision ((MVIS)) has held its Q4 earnings call. Read on for the main highlights of the call.

MicroVision’s latest earnings call painted a mixed picture for investors. Management highlighted strategic wins from the Luminar and Scantinel deals, a broader lidar product lineup and renewed customer engagement, along with clear revenue guidance for 2026. Yet these positives were overshadowed by a steep 2025 revenue drop, sizable noncash impairments and persistent high cash burn that leave execution risk firmly in focus.

Expanded Lidar Stack Spans Automotive, Industrial and Defense

MicroVision underscored how the Luminar and Scantinel acquisitions have transformed its product portfolio. The company now offers MOVIA short-range solid-state sensors, IRIS and HALO long-range units, plus a 1550 nm FMCW sensor, all tied together by MOSAIK and SENTINEL perception software to deliver a full stack from silicon to system for automotive, industrial and security & defense markets.

New Customers and Restarted Programs Boost Commercial Traction

The Luminar integration has immediately expanded MicroVision’s commercial footprint, adding about 30 customer relationships. Management said it restarted previously paused programs, with IRIS shipments resuming in the first month after the deal, and is now cross-selling products across the combined customer base to accelerate the conversion of existing contracts into revenue.

Defense and Security Demand Builds Around 1550 nm and MOVIA L

Defense and security customers are emerging as a key pillar of the growth story, leveraging Scantinel’s 1550 nm FMCW technology, which is invisible to night vision and suited for long-range applications. MOVIA L shipments to a European security and defense OEM began in December and have already generated repeat orders, with demand expected to extend at least into 2026.

Management Sets 2026 Revenue Bar at $10–$15 Million

MicroVision issued explicit 2026 revenue guidance of $10 million to $15 million, a sharp step up from current levels. The outlook assumes successful conversion of Luminar-derived contracts and shipments across both short-range MOVIA products and long-range sensors, and management emphasized this range as a sign of confidence in the new portfolio’s commercial potential.

Cost Controls Cut Cash-Based Operating Expenses in 2025

In contrast to the weak top line, MicroVision pointed to real progress on operating discipline. Cash-based operating expenses for 2025 were $45.5 million, down $14.4 million or 24% from 2024, driven by lower headcount and reduced purchased services, which management framed as a necessary reset to support a more sustainable cost structure.

Cash Burn Eases but Liquidity Still Relies on Financing

Cash used in operations for 2025 fell to $58.7 million, a 14% improvement from the prior year, and year-end liquidity included $74.8 million in cash, equivalents and securities plus $43 million of remaining capacity on an at-the-market facility. The company also issued $43 million of senior secured convertible notes, using part of the proceeds to repay a $19.5 million note while extending its cash runway.

MOVIA S Poised to Drive Industrial Revenue from Late 2026

Short-range MOVIA S is emerging as a key industrial growth lever, with customer interest picking up following its launch. Management expects MOVIA S production to begin in the fourth quarter of the year, positioning the product to start contributing to industrial revenue in 2026 and potentially underpinning growth through 2027.

Consolidation Aims to Streamline Operations and Manufacturing

To further rationalize its footprint, MicroVision plans to consolidate engineering, manufacturing and supply chain operations in Orlando, its main U.S. manufacturing hub. The company will retain strategic sites in Germany and Colorado, seeking both cost synergies and closer alignment with security and defense requirements while reducing overhead from duplicate facilities.

Severe 2025 Revenue Drop Highlights Commercial Execution Gap

Despite the repeated emphasis on pipeline and product breadth, reported revenue sharply deteriorated. Q4 2025 revenue slid to $0.2 million from $1.7 million a year earlier, and full-year revenue fell to $1.2 million from $4.7 million, a roughly 74% decline largely attributed to the absence of a one-time last-time buy in 2024 for legacy Ibeo sensors.

Heavy Noncash Impairments Signal Portfolio and Inventory Reset

A major theme of the quarter was balance sheet cleanup via large noncash charges. In Q4 2025 the company booked $29.4 million in asset impairment and adverse purchase commitments, including $16 million tied to MOVIA L inventory and commitments and $13.4 million associated with perception software and MAVIN equipment, effectively resetting expectations for select legacy assets.

More Impairments and Restructuring Costs on the Way

The reset is not entirely behind the company, as management flagged additional hits to 2026 results. It expects further asset impairment charges of about $8 million to $12 million tied to Redmond office and lease consolidation, plus $1 million to $2 million in people-related restructuring costs as it streamlines its organizational structure.

Cash Use Remains High Relative to Revenue Scale

Even with improving trends, MicroVision’s cash consumption remains heavy compared with its small revenue base. Management projects combined cash use in operations and capital expenditures of $65 million to $70 million in 2026, implying the business will continue to depend on external financing while it works to scale sales from its expanded lidar portfolio.

Q4 Expense Spike Masks Underlying Cash Cost Base

Headline Q4 operating expenses soared to $25.3 million under GAAP, reflecting $13.4 million of noncash charges, but cash-based operating expenses were $11.9 million. That figure was still $0.9 million above Q3, with management attributing part of the increase to investments in an aerial systems team as it seeks to broaden applications for its sensing technology.

Strategic Progress Outpaces the Near-Term Financials

Overall, MicroVision’s operational narrative is stronger than its current financial statements suggest. While the company now boasts a broad product suite, deeper customer relationships and multiple end markets, it remains reliant on convertible notes and the ATM facility, leaving shareholders exposed to dilution and liquidity risk if customer conversions or product ramps fall short of guidance.

Automotive Volume Ramps Pushed Toward the Late Decade

Investors hoping for near-term automotive scale will need patience, as management reiterated that meaningful automotive volume is a late-decade event. Large-scale ramps are now expected in the 2028 to 2031 timeframe, implying that the sizable automotive total addressable market is more of a long-term opportunity than a driver of results over the next few years.

Guidance Highlights Modest Revenue Growth and Positive Margins

Looking ahead, MicroVision guided to 2026 revenue of $10 million to $15 million and total cash use in operations plus CapEx of $65 million to $70 million, with margins expected to be positive. The forecast leans on converting Luminar-related revenues and MicroVision’s prior plans, with the planned Q4 start of MOVIA S production seen as an important contributor to sales momentum as the year progresses.

MicroVision’s earnings call left investors weighing promising strategic positioning against stubbornly weak near-term results and continued cash burn. The expanded lidar portfolio, defense traction and defined 2026 revenue targets offer a clearer growth roadmap, but substantial execution risk and reliance on external funding mean the next two years will be critical in proving that the strategy can translate into sustainable scale.